Bloomington, Indiana — In alignment with its 5-year strategic plan, Cook Medical announced today that CooperCompanies has acquired select products from Cook’s Maternal Fetal Medicine portfolio, as well as gynecological surgery products, and Doppler monitor technology. CooperCompanies (Nasdaq: COO), a publicly held healthcare company, is focused on improving lives one person at a time. CooperCompanies and Cook Medical closed the $300 million agreement earlier today.
“Our vision is to get back to what we were founded on, delivering a continuous stream of innovative new products and services to address unmet customer needs. Reaching this vision requires careful planning, a lot of hard work, and deliberate choices including a full review of our product portfolio to ensure strategic fit for the future,” said Pete Yonkman, president of Cook Medical and Cook Group. “This agreement will allow us to invest in future growth and new technologies while also allowing the new Cooper product lines to thrive and meet patients’ needs around the world. The rest of the Cook organization will continue as privately held, family-owned companies.”
Transaction details:
- The sale includes a large portion of Cook’s MFM products, gynecological surgery products, as well as the Doppler monitor technology, disposable devices, and accessories.
- Cook will continue to manufacture these products for at least two years. During this two-year period, manufacturing will be transferred to CooperSurgical.
- No manufacturing jobs are at risk.
- These product lines represent approximately 2.5% of Cook’s overall sales.
About Cook Medical
Since 1963, Cook Medical has been inventing, manufacturing, and delivering a unique portfolio of medical devices to healthcare systems around the world. We work closely with physicians to develop technologies that improve patients’ lives. Because we remain family owned, we have the freedom to focus on what we care about: our patients, our employees, and our communities. Find out more at CookMedical.com , and for the latest news, follow us on LinkedIn, Twitter, and Facebook.